- fewer new drugs being introduced
- heavy publicity for some nasty side effects (e.g. rosiglitazone)
- a slowdown in FDA approvals
Physician visits were also down 1.2%. But medical workers shouldn't worry about unemployment quite yet, experts said. The American population is still expected to get older and sicker in the future, so we can expect business to pick back up. What a relief.